$-0.17
(Market cap
$2,543 Mln
Revenue (TTM)
$870 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
18.6
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
218,106,005
10 Years Aggregate
CFO
$570.07 Mln
EBITDA
$746.45 Mln
Net Profit
$411.16 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Neogen (NEOG)
| 66.5 | -3.3 | 33.0 | 106.4 | -20.7 | -23.5 | -6.5 |
|
BSE Sensex
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Neogen (NEOG)
| -42.4 | -39.4 | 32.0 | -66.5 | 14.5 | 21.5 | 14.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Neogen (NEOG)
|
11.6 | 2,543.1 | 870.4 | -7.9 | 5.8 | -0.4 | -- | 1.2 |
| 0.3 | 32.7 | 402.0 | -49.2 | -3.6 | -80.1 | -- | 0.8 | |
| 15.5 | 655.1 | 320.2 | -36.7 | -11.2 | -20.8 | -- | 3.8 | |
| 229.2 | 32,953.0 | 5,653.4 | 1,523.3 | 34.5 | 24.3 | 22.1 | 5.1 | |
| 18.4 | 371.9 | 82.1 | 8.1 | 13.2 | 6.1 | 46 | 2.7 |
Shareholding Pattern
View DetailsAbout Neogen (NEOG)
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test... kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Read more
-
President, CEO & Director
Mr. John Edward Adent
-
President, CEO & Director
Mr. John Edward Adent
-
Headquarters
Lansing, MI
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Neogen (NEOG)
What is the current share price of Neogen Corporation (NEOG) Today?
The share price of Neogen Corporation (NEOG) is $11.64 (NASDAQ) as of 03-Sep-2026 16:00 EDT. Neogen Corporation (NEOG) has given a return of -20.69% in the last 3 years.
What is the current PB & PE ratio of Neogen Corporation (NEOG)?
Since, TTM earnings of Neogen Corporation (NEOG) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-- |
-- |
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
What is the 52 Week High and Low of Neogen Corporation (NEOG)?
The 52-week high and low of Neogen Corporation (NEOG) are Rs 12.85 and Rs 4.90 as of 04-Sep-2026.
What is the market cap of Neogen Corporation (NEOG)?
Neogen Corporation (NEOG) has a market capitalisation of $ 2,543 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Neogen Corporation (NEOG)?
Before investing in Neogen Corporation (NEOG), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.